Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
Haematologica|August 1, 2020
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphomaPaolo Strati, Ankur Varma, Sherry Adkins, et al.British Journal of Haematology|July 23, 2016
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic modelYiming Chen, Sattva Neelapu, Lei Feng, et al.Leukemia & Lymphoma|August 9, 2021
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphomaLoretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, et al.British Journal of Haematology|August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphomaDai Chihara, Barbara Pro, Sanam Loghavi, et al.Cancer|June 29, 2016
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphomaDai Chihara, Jason R Westin, Yasuhiro Oki, et al.Blood Advances|June 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphomaNeha Akkad, Lei Feng, Jason R Westin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2019
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent LymphomaJohn P Leonard, Marek Trneny, Koji Izutsu, et al.Blood Advances|August 16, 2022
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphomaGilles Salles, Stephen J Schuster, Martin Dreyling, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized TrialsQian Shi, Christopher R Flowers, Wolfgang Hiddemann, et al.Plos One|March 15, 2018
The risk of central nervous system relapses in patients with peripheral T-cell lymphomaDai Chihara, Michelle A Fanale, Roberto N Miranda, et al.Pageof 6